Quarterly Financial Data (Tables)

12 Months Ended

Dec. 31, 2020

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information

	2020
	1st		2nd		3rd		4th		Total
Net sales	$	923.4	$	803.5	$	894.6	$	891.7	$	3,513.2
Gross profit	278.9		230.3		263.7		237.0		1,009.9
Selling, general and administrative expenses	153.6		111.8		132.7		135.7		533.8
Impairment and restructuring charges	3.6		3.1		12.0		2.5		21.2
Net income (1)	84.0		61.8		91.3		55.3		292.4
Net income attributable to noncontrolling interests	3.3		(0.1)		2.5		2.2		7.9
Net income attributable to The Timken Company	80.7		61.9		88.8		53.1		284.5
Net income per share - Basic:	$	1.07	$	0.82	$	1.18	$	0.70	$	3.78
Net income per share - Diluted:	$	1.06	$	0.82	$	1.16	$	0.69	$	3.72
Dividends per share	$	0.28	$	0.28	$	0.28	$	0.29	$	1.13
	2019
	1st		2nd		3rd		4th		Total
Net sales	$	979.7	$	1,000.0	$	914.0	$	896.2	$	3,789.9
Gross profit	302.6		305.7		277.5		256.0		1,141.8
Selling, general and administrative expenses	152.7		158.7		148.0		159.2		618.6
Impairment and restructuring charges	—		1.9		1.6		3.3		6.8
Net income (2)	95.3		94.9		66.7		117.8		374.7
Net income attributable to noncontrolling interests	3.4		2.4		2.5		4.3		12.6
Net income attributable to The Timken Company	91.9		92.5		64.2		113.5		362.1
Net income per share - Basic:	$	1.21	$	1.22	$	0.85	$	1.51	$	4.78
Net income per share - Diluted:	$	1.19	$	1.20	$	0.84	$	1.48	$	4.71
Dividends per share	$	0.28	$	0.28	$	0.28	$	0.28	$	1.12

Earnings per share are computed independently for each of the quarters presented; therefore, the sum of the quarterly earnings per share may not equal the total computed for the year.

(1)Net income for the second quarter of 2020 included net actuarial losses of $8.8 million. Net income for the third quarter of 2020 included net actuarial gains of $11.9 million and impairment and restructuring charges of $12.0 million. Net income for the fourth quarter of 2020 included net actuarial losses of $21.6 million.

(2)Net income for the third quarter of 2019 included net actuarial losses of $16.9 million, Net income for the fourth quarter of 2019 included the reversal of tax valuation allowances of $44.5 million and net actuarial gains of $21.1 million.